Hak-Sung Kim Selected Research

N-carbamoylamino acid amidohydrolase

6/2002

Modeling and kinetic analysis of the reaction system using whole cells with separately and co-expressed D-hydantoinase and N-carbamoylase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hak-Sung Kim Research Topics

Disease

19	Neoplasms (Cancer) 08/2020 - 04/2013
3	Fatigue 01/2016 - 03/2015
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 02/2008 - 11/2005
2	Acute Coronary Syndrome 09/2014 - 08/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014 - 09/2010
2	Lung Neoplasms (Lung Cancer) 08/2013 - 12/2009
2	Type I Syndactyly 06/2004 - 06/2002
1	Carcinogenesis 09/2021
1	Triple Negative Breast Neoplasms 09/2021
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Lymphoma (Lymphomas) 01/2020
1	Sepsis (Septicemia) 01/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Rheumatoid Arthritis 01/2016
1	Pathologic Neovascularization 01/2016
1	Choroidal Neovascularization 01/2016
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016
1	Circulating Neoplastic Cells 06/2015
1	Stroke (Strokes) 09/2014
1	Ovarian Neoplasms (Ovarian Cancer) 08/2013
1	Chest Pain (Chest Pains) 08/2012
1	Hypersensitivity (Allergy) 05/2007
1	Metrorrhagia (Spotting) 11/2006

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 08/2020 - 11/2005
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 09/2010
2	Phosphotransferases (Kinase)IBA 02/2020 - 01/2020
2	Chelating AgentsIBA 01/2018 - 04/2013
2	Leucine (L-Leucine)FDA Link 01/2018 - 01/2017
2	Radioisotopes (Radionuclides)IBA 01/2017 - 04/2013
2	CopperIBA 11/2015 - 03/2015
2	EnzymesIBA 08/2012 - 02/2008
2	Peptides (Polypeptides)IBA 02/2008 - 03/2006
2	dihydropyrimidinaseIBA 06/2004 - 06/2002
1	Interleukin-8 (Interleukin 8)IBA 09/2021
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	ExotoxinsIBA 01/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2018
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2018
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Gelonium multiflorum GEL proteinIBA 11/2017
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2017
1	AnaphylatoxinsIBA 01/2016
1	SilverIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Carbon Nanotubes (Carbon Nanotube)IBA 11/2015
1	Pharmaceutical PreparationsIBA 06/2015
1	TriterpenesIBA 03/2015
1	von Willebrand FactorIBA 09/2014
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 08/2013
1	Liposomes (Liposome)IBA 08/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2013
1	NucleotidesIBA 08/2013
1	AlbuminsIBA 08/2012
1	Troponin IIBA 08/2012
1	CobaltIBA 08/2012
1	ImmunosorbentsIBA 08/2012
1	AllergensIBA 05/2007
1	Immunoglobulin E (IgE)IBA 05/2007
1	AntibodiesIBA 11/2006
1	AminesIBA 03/2006
1	QuartzIBA 03/2006
1	Dendrimers (Dendrons)IBA 11/2005
1	Biotin (Vitamin H)FDA Link 11/2005
1	StreptavidinIBA 11/2005
1	Lysine (L-Lysine)FDA Link 11/2005
1	4-hydroxyphenylglycine (oxfenicine)IBA 06/2002
1	HydantoinsIBA 06/2002
1	N-carbamoylamino acid amidohydrolaseIBA 06/2002

Therapy/Procedure

6	Therapeutics 09/2021 - 07/2014
1	Immunotherapy 01/2020
1	Intravenous Injections 01/2018
1	Injections 01/2017
1	Quantum Dots (Quantum Dot) 06/2015
1	Electrodes (Electrode) 03/2015
1	Radioimmunotherapy 04/2013